Lack of association of ankylosing spondylitis with the most common NOD2 susceptibility alleles to Crohn's disease

Journal of Rheumatology

Volumn 30, Issue 1, 2003, Pages 102-104

  Ferreirós Vidal, Isabel ^a   Amarelo, Juan ^a   Barros, Francisco ^b   Carracedo, Angel ^b   Gómez Reino, Juan J ^a   Gonzalez, Antonio ^a  

^a Instituto de Salud Carlos III   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Ankylosing spondylitis; Autoimmune diseases; Crohn's disease; Genetic predisposition to disease

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; HLA B27 ANTIGEN; PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; AUTOIMMUNE DISEASE; CHROMOSOME 16Q; CONTROLLED STUDY; CROHN DISEASE; DISEASE PREDISPOSITION; DNA DETERMINATION; GENE FREQUENCY; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

CARRIER PROTEINS; CHROMOSOMES, HUMAN, PAIR 16; CROHN DISEASE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; RISK FACTORS; SPONDYLITIS, ANKYLOSING;

EID: 0037227353     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996;85:311-8.
2. Becker KG, Simon RM, Bailey-Wilson JE, et al. Clustering of nonmajor histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA 1998;95:9979-84.
3. Wandstrat A, Wakeland EK. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat Immun 2001;2:802-9.
4. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
5. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
6. Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001;357:1925-8.
7. Brown MA, Laval SH, Brophy S, Calin A. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis 2000;59:883-6.
8. Brown MA, Pile KD, Kennedy LG, et al. A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum 1998;41:588-95.
9. Laval SH, Timms A, Edwards S, et al. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 2001;68:918-26.
10. Smale S, Natt RS, Orchard TR, Russell AS, Bjarnason I. Inflammatory bowel disease and spondyloarthropathy. Arthritis Rheum 2001;44:2728-36.
11. Gravallese EM, Kantrowitz FG. Arthritic manifestations of inflammatory bowel disease. Am J Gastroenterol 1988;83:703-9.
12. Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 1998;42:387-91.
13. Brophy S, Pavy S, Lewis P. et al. Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic and environmental factors. J Rheumatol 2001;28:2667-73.
14. Bollow M, Fischer T, Reisshauer H, et al. Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis-cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Ann Rheum Dis 2000;59:135-40.
15. Burgio VL, Fais S, Boirivant M, Perrone A, Pallone F. Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease. Gastroenterology 1995;109:1029-38.
16. Targan SR, Hanauer SB, van Deventer S, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997;337:1029-35.
17. Baeten D, Kruithof E, van den Bosch F, et al. Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study. Arthritis Rheum 2001;44:186-95.
18. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
19. Collado-Escobar MD, Nieto A, Mataran L, Raya E, Martín J. Interleukin 6 promoter polymorphism is not associated with ankylosing spondylitis. J Rheumatol 2000;27:1461-3.
20. Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:845-57.
21. Sieper J, Braun J. Pathogenesis of spondylarthropathies. Persistent bacterial antigen, autoimmunity, or both? Arthritis Rheum 1995:38:1547-54.
22. Nair RP, Stuart P, Ogura Y, et al. Lack of association between NOD2 3020InsC frameshift mutation and psoriasis. J Invest Dermatol 2001;117:1671-2.